Literature DB >> 17486380

Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis.

Brian T Ragel1, William T Couldwell, David L Gillespie, Randy L Jensen.   

Abstract

Overcoming the metabolic restrictions of hypoxia may allow the progression of lower-grade tumors to glioblastoma multiforme. Our findings of up-regulation of HIF-1alpha and its downstream targets VEGF, GLUT-1, and CAIX in higher-grade gliomas support this hypothesis. We compared the gene expression profiles of the U-251 malignant glioma cell line under normoxic and hypoxic conditions to discover future research targets. U-251 cells were grown to 75% confluence and exposed to either normoxic or hypoxic conditions for 24 h. RNA was extracted, amplified, and hybridized to a cDNA microarray chip containing ~8,800 universal cellular genes. A threefold increase in mRNA expression was used as a threshold value for differential expression. Identified genes were divided into cell cycle control, stress response, and "newly connected" genes. Hybridization identified 11 hypoxia-induced genes: 1 involved with cell cycle control (CCNG2), 6 in stress response (IGFBP3, SLC2A3, GSTT2, FOS, DDIT3, AKR1C3), and 2 newly connected genes (Depp, AKAP4). One stress-related gene (AKR1C3) encodes for an enzyme that synthesizes progesterone. Of newly connected genes, the gene decidual protein induced by progesterone (Depp) showed the highest expression (4.2-fold increase). Possible future targeting for "hypoxic" glioma cells includes the targets for the AP-1 transcription factor complex (FOS), as well as blockade of the enzyme AKR1C3 with nonsteroidal anti-inflammatory drugs. Possible functions of the highly expressed gene Depp include tumor vascularization. Future studies will focus on the hypothesis that Depp is up-regulated in an autocrine fashion by the AKR1C3 enzyme in U-251 glioma cells under hypoxic conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486380     DOI: 10.1007/s10143-007-0070-z

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   2.800


  41 in total

Review 1.  Insulin-like growth factor binding proteins: new proteins, new functions.

Authors:  R J Ferry; R W Cerri; P Cohen
Journal:  Horm Res       Date:  1999

Review 2.  Fibrous sheath of mammalian spermatozoa.

Authors:  Edward M Eddy; Kiyotaka Toshimori; Deborah A O'Brien
Journal:  Microsc Res Tech       Date:  2003-05-01       Impact factor: 2.769

3.  A novel protein Depp, which is induced by progesterone in human endometrial stromal cells activates Elk-1 transcription factor.

Authors:  Hirohiko Watanabe; Kohsuke Nonoguchi; Toshiharu Sakurai; Tomoko Masuda; Katsuhiko Itoh; Jun Fujita
Journal:  Mol Hum Reprod       Date:  2005-07       Impact factor: 4.025

4.  Distribution of the glucose transporters in human brain tumors.

Authors:  T Nishioka; Y Oda; Y Seino; T Yamamoto; N Inagaki; H Yano; H Imura; R Shigemoto; H Kikuchi
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

5.  Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.

Authors:  K-M Fung; E N S Samara; C Wong; A Metwalli; R Krlin; B Bane; C Z Liu; J T Yang; J V Pitha; D J Culkin; B P Kropp; T M Penning; Hsueh-Kung Lin
Journal:  Endocr Relat Cancer       Date:  2006-03       Impact factor: 5.678

6.  Proto-oncogene analyses in brain tumors.

Authors:  M Fujimoto; P J Sheridan; Z D Sharp; F J Weaker; S Kagan-Hallet; J L Story
Journal:  J Neurosurg       Date:  1989-06       Impact factor: 5.115

7.  Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.

Authors:  P J Ciaccio; H Shen; A K Jaiswal; M H Lyttle; K D Tew
Journal:  Mol Pharmacol       Date:  1995-10       Impact factor: 4.436

8.  Neurobeachin is essential for neuromuscular synaptic transmission.

Authors:  Yuhua Su; Rita J Balice-Gordon; Darren M Hess; Douglas S Landsman; Jeremy Minarcik; Jeffrey Golden; Ivy Hurwitz; Stephen A Liebhaber; Nancy E Cooke
Journal:  J Neurosci       Date:  2004-04-07       Impact factor: 6.167

9.  Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect.

Authors:  Audrey Carrière; Maria-Carmen Carmona; Yvette Fernandez; Michel Rigoulet; Roland H Wenger; Luc Pénicaud; Louis Casteilla
Journal:  J Biol Chem       Date:  2004-07-20       Impact factor: 5.157

10.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more
  26 in total

1.  Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.

Authors:  Atsushi Fujimura; Hiroyuki Michiue; Yan Cheng; Atsuhito Uneda; Yasunari Tani; Tei-ichi Nishiki; Tomotsugu Ichikawa; Fan-Yan Wei; Kazuhito Tomizawa; Hideki Matsui
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

2.  Recruitment of cyclin G2 to promyelocytic leukemia nuclear bodies promotes dephosphorylation of γH2AX following treatment with ionizing radiation.

Authors:  Yoko Naito; Norikazu Yabuta; Jun Sato; Shouichi Ohno; Muneki Sakata; Takashi Kasama; Masahito Ikawa; Hiroshi Nojima
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

3.  AKAP4 mediated tumor malignancy in esophageal cancer.

Authors:  Shujun Li; Xuebo Qin; Yanjie Li; Anrui Guo; Liguo Ma; Fang Jiao; Song Chai
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Experimental validation of 5 in-silico predicted glioma biomarkers.

Authors:  Rheal A Towner; Randy L Jensen; Brian Vaillant; Howard Colman; Debra Saunders; Cory B Giles; Jonathan D Wren
Journal:  Neuro Oncol       Date:  2013-10-24       Impact factor: 12.300

5.  Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.

Authors:  Aubrey L Park; Hsueh-Kung Lin; Qing Yang; Chor Wing Sing; Michael Fan; Timothy B Mapstone; Naina L Gross; Mary K Gumerlock; Michael D Martin; Craig H Rabb; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2010-03-25

6.  ELTD1, a potential new biomarker for gliomas.

Authors:  Rheal A Towner; Randy L Jensen; Howard Colman; Brian Vaillant; Nataliya Smith; Rebba Casteel; Debra Saunders; David L Gillespie; Robert Silasi-Mansat; Florea Lupu; Cory B Giles; Jonathan D Wren
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

7.  ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53.

Authors:  S Ohno; Y Naito; S Mukai; N Yabuta; H Nojima
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 8.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  Quantile Function on Scalar Regression Analysis for Distributional Data.

Authors:  Hojin Yang; Veerabhadran Baladandayuthapani; Arvind U K Rao; Jeffrey S Morris
Journal:  J Am Stat Assoc       Date:  2019-06-21       Impact factor: 5.033

10.  Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts.

Authors:  David R Mole; Christine Blancher; Richard R Copley; Patrick J Pollard; Jonathan M Gleadle; Jiannis Ragoussis; Peter J Ratcliffe
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.